ArticleNeuro-oncology2025

Response to: Bayesian -reappraisal of ACNS0332 and ACNS0334 strengthens -subgroup treatment effects in high-risk pediatric group 3 medulloblastoma.

Guolian Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.